Cabaletta Bio (CABA) Free Cash Flow (2018 - 2025)

Cabaletta Bio's Free Cash Flow history runs 8 years deep, the most recent figure standing at -$35.3 million for Q4 2025.

• On a quarterly basis, Free Cash Flow fell 50.41% year-over-year to -$35.3 million in Q4 2025; TTM through Dec 2025 was -$131.1 million, a 44.95% decrease from a year earlier, with the FY2025 full-year figure at -$131.1 million, down 44.95% from the prior year.
• Free Cash Flow declined to -$35.3 million in Q4 2025 per CABA's latest filing, from -$34.5 million in the prior quarter.
• Across five years, Free Cash Flow topped out at -$7.0 million in Q2 2021 and bottomed at -$35.3 million in Q4 2025.
• The 5-year median for Free Cash Flow is -$13.0 million (2022), against an average of -$17.9 million.
• Across the five-year window, Free Cash Flow advanced 13.88% in 2022 and sank 95.51% in 2024, its largest moves.
• Year by year, Free Cash Flow stood at -$11.6 million in 2021, then gained by 13.88% to -$10.0 million in 2022, then slumped by 66.58% to -$16.6 million in 2023, then plunged by 41.15% to -$23.5 million in 2024, then tumbled by 50.41% to -$35.3 million in 2025.
• Per Business Quant, the three latest CABA Free Cash Flow figures stand at -$35.3 million (Q4 2025), -$34.5 million (Q3 2025), and -$29.7 million (Q2 2025).